Safety Notices

From time to time notices relating to the safety and/or quality of medicinal products are published by the Health Products Regulatory Authority

These notices are classified under several priority related categories and may relate to human and veterinary medicines, or medical devices.   

The issues covered by these notices will range from quality defect information and medicinal product safety information through to updated information on the appropriate usage of medicines or devices.

Notices are categorised in accordance with their importance at time of publication.

The four notice categories are outlined as follows:

  • Advisory  -  Routine safety information            
  • Warning  -  Urgent safety information
  • Recall  -  Urgent safety information relating to a product recall
  • Publications  -  General safety information provided by the HPRA for publication via 3rd parties e.g. MIMS

The HPRA Drug Safety Newsletter is also published on a regular basis.

Date Title Type
11/03/2020 Medicinal Product Shortages - update - 11 March 2020 Advisory
04/03/2020 Medicinal Product Shortages - update - 4 March 2020 Advisory
26/02/2020 Medicinal Product Shortages - update - 26 February 2020 Advisory
19/02/2020 Medicinal Product Shortages - update - 19 February 2020 Advisory
17/02/2020 XELJANZ (tofacitinib): Important Safety Information from Pfizer Healthcare Ireland as approved by the HPRA 3rd Party Publications
13/02/2020 HPRA MIMS Article January 2020 3rd Party Publications
13/02/2020 HPRA MIMS Articles December 2019 3rd Party Publications
12/02/2020 Medicinal Product Shortages - update - 12th February 2020 Advisory
05/02/2020 Medicinal Product Shortages - update - 5 February 2020 Advisory
30/01/2020 Picato (ingenol mebutate) - Important Safety Information from LEO Pharma as approved by the HPRA 3rd Party Publications